-
1
-
-
0024391923
-
Neuropsychological assessment of the severely impaired elderly patient
-
Saxton J, Swihart AA,. Neuropsychological assessment of the severely impaired elderly patient. Clin Geriatr Med 1989; 5: 531-43.
-
(1989)
Clin Geriatr Med
, vol.5
, pp. 531-543
-
-
Saxton, J.1
Swihart, A.A.2
-
2
-
-
0030801505
-
The severe impairment battery: Concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study
-
Schmitt FA, Ashford W, Ernesto C, et al. The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997; 11 (Suppl. 2): S51-6.
-
(1997)
Alzheimer Dis Assoc Disord
, vol.11
, Issue.SUPPL. 2
-
-
Schmitt, F.A.1
Ashford, W.2
Ernesto, C.3
-
3
-
-
34548081204
-
Donepezil preserves cognition and global function in patients with severe Alzheimer disease
-
Black SE, Doody R, Li H, et al. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology 2007; 69: 459-69.
-
(2007)
Neurology
, vol.69
, pp. 459-469
-
-
Black, S.E.1
Doody, R.2
Li, H.3
-
4
-
-
47849098036
-
Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease
-
Emre M, Mecocci P, Stender K,. Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease. J Alzheimers Dis 2008; 14: 193-9.
-
(2008)
J Alzheimers Dis
, vol.14
, pp. 193-199
-
-
Emre, M.1
Mecocci, P.2
Stender, K.3
-
5
-
-
43049134839
-
Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: Results from a 24-week, double-blind, placebo-controlled, randomized trial
-
Homma A, Imai Y, Tago H, et al. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial. Dement Geriatr Cogn Disord 2008; 25: 399-407.
-
(2008)
Dement Geriatr Cogn Disord
, vol.25
, pp. 399-407
-
-
Homma, A.1
Imai, Y.2
Tago, H.3
-
6
-
-
33748567769
-
A systematic review of assessment and treatment of moderate to severe Alzheimer's disease
-
Schmitt FA, Wichems CH,. A systematic review of assessment and treatment of moderate to severe Alzheimer's disease. Prim Care Companion J Clin Psychiatry 2006; 8: 158-9.
-
(2006)
Prim Care Companion J Clin Psychiatry
, vol.8
, pp. 158-159
-
-
Schmitt, F.A.1
Wichems, C.H.2
-
7
-
-
33645741379
-
Donepezil in patients with severe Alzheimer's disease: Double-blind, parallel-group, placebo-controlled study
-
Winblad B, Kilander L, Eriksson S, et al. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Lancet 2006; 367: 1057-65.
-
(2006)
Lancet
, vol.367
, pp. 1057-1065
-
-
Winblad, B.1
Kilander, L.2
Eriksson, S.3
-
8
-
-
69949154414
-
Treatment effects of memantine on language in moderate to severe Alzheimer's disease patients
-
Ferris S, Ihl R, Robert P, et al. Treatment effects of memantine on language in moderate to severe Alzheimer's disease patients. Alzheimers Dement 2009; 5: 369-74.
-
(2009)
Alzheimers Dement
, vol.5
, pp. 369-374
-
-
Ferris, S.1
Ihl, R.2
Robert, P.3
-
9
-
-
23844474755
-
Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease
-
Galasko D, Schmitt F, Thomas R, Jin S, Bennett D,. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. J Int Neuropsychol Soc 2005; 11: 446-53.
-
(2005)
J Int Neuropsychol Soc
, vol.11
, pp. 446-453
-
-
Galasko, D.1
Schmitt, F.2
Thomas, R.3
Jin, S.4
Bennett, D.5
-
10
-
-
75949130369
-
A brief instrument to assess treatment response in the patient with advanced Alzheimer disease
-
Schmitt FA, Saxton JA, Xu Y, et al. A brief instrument to assess treatment response in the patient with advanced Alzheimer disease. Alzheimer Dis Assoc Disord 2009; 23: 377-83.
-
(2009)
Alzheimer Dis Assoc Disord
, vol.23
, pp. 377-383
-
-
Schmitt, F.A.1
Saxton, J.A.2
Xu, Y.3
-
11
-
-
77955253242
-
Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study
-
Farlow MR, Salloway S, Tariot PN, et al. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: a 24-week, randomized, double-blind study. Clin Ther 2010; 32: 1234-51.
-
(2010)
Clin Ther
, vol.32
, pp. 1234-1251
-
-
Farlow, M.R.1
Salloway, S.2
Tariot, P.N.3
-
13
-
-
80052025326
-
Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease
-
Ferris SH, Schmitt FA, Saxton J, et al. Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease. Alzheimers Res Ther 2011; 3: 22.
-
(2011)
Alzheimers Res Ther
, vol.3
, pp. 22
-
-
Ferris, S.H.1
Schmitt, F.A.2
Saxton, J.3
-
14
-
-
0030819805
-
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: Overview and general results. The Alzheimer's Disease Cooperative Study
-
Ferris SH, Mackell JA, Mohs R, et al. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997; 11 (Suppl. 2): S1-12.
-
(1997)
Alzheimer Dis Assoc Disord
, vol.11
, Issue.SUPPL. 2
-
-
Ferris, S.H.1
MacKell, J.A.2
Mohs, R.3
-
15
-
-
0028152357
-
Severe impairment battery. A neuropsychological test for severely demented patients
-
Panisset M, Roudier M, Saxton J, Boller F,. Severe impairment battery. A neuropsychological test for severely demented patients. Arch Neurol 1994; 51: 41-5.
-
(1994)
Arch Neurol
, vol.51
, pp. 41-45
-
-
Panisset, M.1
Roudier, M.2
Saxton, J.3
Boller, F.4
-
16
-
-
16844383073
-
Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: A 12-month analysis
-
Feldman HH, Van BB, Kavanagh SM, Torfs KE,. Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis. Alzheimer Dis Assoc Disord 2005; 19: 29-36.
-
(2005)
Alzheimer Dis Assoc Disord
, vol.19
, pp. 29-36
-
-
Feldman, H.H.1
Van, B.B.2
Kavanagh, S.M.3
Torfs, K.E.4
-
17
-
-
0036176148
-
Factorial validation of the Severe Impairment Battery for patients with Alzheimer's disease. A pilot study
-
Pelissier C, Roudier M, Boller F,. Factorial validation of the Severe Impairment Battery for patients with Alzheimer's disease. A pilot study. Dement Geriatr Cogn Disord 2002; 13: 95-100.
-
(2002)
Dement Geriatr Cogn Disord
, vol.13
, pp. 95-100
-
-
Pelissier, C.1
Roudier, M.2
Boller, F.3
|